Efficient Generation of Hepatoblasts From Human ES Cells and iPS Cells by Transient Overexpression of Homeobox Gene HEX by Inamura, Mitsuru et al.
original article
400  www.moleculartherapy.org  vol. 19 no. 2, 400–407 feb. 2011           
© The American Society of Gene & Cell Therapy
Human embryonic stem cells (ESCs) and induced pluri-
potent stem cells (iPSCs) have the potential to differenti-
ate into all cell lineages, including hepatocytes, in vitro. 
Induced  hepatocytes  have  a  wide  range  of  potential 
application in biomedical research, drug discovery, and 
the treatment of liver disease. However, the existing pro-
tocols for hepatic differentiation of PSCs are not very effi-
cient. In this study, we developed an efficient method to 
induce  hepatoblasts,  which  are  progenitors  of  hepato-
cytes, from human ESCs and iPSCs by overexpression of 
the HEX gene, which is a homeotic gene and also essential 
for hepatic differentiation, using a HEX-expressing adeno-
virus (Ad) vector under serum/feeder cell-free chemically 
defined  conditions.  Ad-HEX-transduced  cells  expressed 
α-fetoprotein (AFP) at day 9 and then expressed albumin 
(ALB) at day 12. Furthermore, the Ad-HEX-transduced cells 
derived from human iPSCs also produced several cyto-
chrome P450 (CYP) isozymes, and these P450 isozymes 
were capable of converting the substrates to metabolites 
and responding to the chemical stimulation. Our differ-
entiation  protocol  using  Ad  vector-mediated  transient 
HEX  transduction  under  chemically  defined  conditions 
efficiently generates hepatoblasts from human ESCs and 
iPSCs. Thus, our methods would be useful for not only 
drug screening but also therapeutic applications.
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IntroductIon
Human embryonic stem cells (ESCs) and induced pluripotent 
stem cells (iPSCs) are able to replicate indefinitely and differ-
entiate into most cell types of the body,1–4 and thereby have the 
potential to provide an unlimited source of cells for a variety of 
applications.5 Hepatocytes are useful cells for biomedical research, 
regenerative medicine, and drug discovery. They are particularly 
applicable to drug screenings, such as for the determination of 
metabolic and toxicological properties of drug compounds in 
in vitro models, because the liver is the main detoxification organ 
in the body.6 For these applications, it is necessary to prepare a 
large number of functional hepatocytes from human ESCs and 
iPSCs. Many of the existing methods for cell differentiation of 
human  ESCs  and  iPSCs  into  hepatocytes  employ  undefined, 
serum-containing  medium  and  feeder  cells.7–9  Preparation  of 
human ESC- and iPSC-derived hepatocytes for therapeutic appli-
cations and drug toxicity testing in humans should be done in 
nonxenogenic culture systems to avoid potential contamination 
with pathogens. Furthermore, the efficiency of the differentiation 
of the human ESCs and iPSCs into hepatocytes is not particularly 
high using these methods.9–14
In vertebrate development, the liver is derived from the prim-
itive gut tube, which is formed by a flat sheet of cells called the 
definitive endoderm.5,15 Shortly afterwards, the definitive endo-
derm is separated into endoderm derivatives containing the liver 
bud, the cells of which are referred to as hepatoblasts. The hepa-
toblasts have the potential to proliferate and differentiate into 
both hepatocytes and cholangiocytes. In the process of hepatic 
differentiation, the maturation is characterized by the expression 
of liver- and stage-specific genes. For example, α-fetoprotein 
(AFP) is an early hepatic marker, which is expressed in hepa-
toblasts in the liver bud until birth, and its expression is dra-
matically  reduced  after  birth.16  In  contrast,  albumin  (ALB), 
which is the most abundant protein synthesized by hepatocytes, 
is initially expressed at lower levels in early fetal hepatocytes, 
but its expression level is increased as the hepatocytes mature, 
reaching a maximum in adult hepatocytes.17 Furthermore, iso-
forms of cytochrome P450 (CYP) proteins also exhibit differ-
ential expression levels according to the developmental stages 
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of the liver. Although most CYPs (including CYP3A4, CYP7A1, 
and CYP2D6) are only slightly expressed or not detected in the 
fetal liver tissue, the expression levels are dramatically increased 
after birth.18
For the development of hepatoblasts, numerous transcrip-
tion factors are required, such as hematopoietically expressed 
homeobox (HEX), GATA-binding protein 6, prospero homeo-
box 1, and hepatocyte nuclear factor 4A.15,19 Among them, HEX 
is suggested to function at the earliest stage of hepatic linage.20 
HEX is first expressed in the definitive endoderm and becomes 
restricted to the future hepatoblasts. Targeted deletion of the 
HEX gene in the mouse results in embryonic lethality and a dra-
matic loss of the fetal liver parenchyma.19,21,22 The hepatic genes, 
including ALB, prospero homeobox1, and hepatocyte nuclear 
factor 4A, are transiently expressed in the definitive endoderm 
of HEX-null embryos, and further morphogenesis of the hepato-
blasts does not occur.23 In general, then, HEX is essential for the 
definitive endoderm to adopt a hepatic cell fate.
Adenovirus (Ad) vectors are one of the most efficient gene 
delivery vehicles and have been widely used in both experimen-
tal studies and clinical trials.24 Ad vectors are attractive vehicles 
for gene transfer because they are easily constructed, can be pre-
pared in high titers, and provide high transduction efficiency in 
both dividing and nondividing cells. We have developed efficient 
methods  for  Ad  vector-mediated  transient  transduction  into 
mouse ESCs and iPSCs.25,26 We have also showed that the differen-
tiations of mouse ESCs and iPSCs into adipocytes and osteoblasts 
were dramatically promoted by Ad vector-mediated peroxisome 
proliferator activated receptor γ and runt related transcription 
factor 2 transduction, respectively.25,26
In this study, we hypothesized that transient HEX transduc-
tion could efficiently induce hepatoblasts from human ESCs and 
iPSCs. A previous study demonstrated that HEX regulates the dif-
ferentiation of hemangioblasts and endothelial cells from mouse 
ESCs,27 whereas the role of HEX in the differentiation of hepato-
blasts from human ESCs and iPSCs remains unknown. We found 
that differentiation of hepatoblasts from the human ESC- and 
iPSC-derived definitive endoderms, but not from undifferenti-
ated human ESCs and iPSCs, could be facilitated by Ad vector-
mediated transient transduction of a HEX gene. Furthermore, the 
Ad-HEX-transduced cells that were derived from human iPSCs 
were able to differentiate into functional hepatocytes in vitro. All 
the processes for cellular differentiation were performed under 
serum/feeder cell- free chemically defined conditions. Our cul-
ture systems and differentiation method based on Ad vector-
mediated  transient  transduction  under  chemically  defined 
conditions would provide a platform for drug screening as well 
as safe therapies.
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Figure 1  A strategy of differentiation of human embryonic stem cells (EScs) and induced pluripotent stem cells (iPScs) to hepatoblasts and 
hepatocytes. (a) Schematic representation illustrating the procedure for differentiation of human ESCs (khES1) and iPSCs (Tic) to hepatocytes. (b–i) 
Phase contrast microscopy showing sequential morphological changes (day 0–12) from (b–e) human ESCs (khES1) and (f–i) iPSCs (Tic) to hepato-
blasts via the definitive endoderm. Bar = 50 μm. bFGF, basic fibroblast growth factor; BMP4, bone morphogenetic protein 4; DEX, dexamethasone; 
FGF4, fibroblast growth factor 4; HGF, hepatocyte growth factor; OSM, Oncostatin M; HCM, hepatocytes culture medium; *, hESF-GRO medium that 
was supplemented with 10 μg/ml human recombinant insulin, 5 μg/ml human apotransferrin, 10 μmol/l 2-mercaptoethanol, 10 μmol/l ethanolamine, 
10 μmol/l sodium selenite, 0.5 mg/ml fatty acid free BSA; **, hESF-DIF medium that was supplemented with 10 μg/ml insulin, 5 μg/ml apotransferrin, 
10 μmol/l 2-mercaptoethanol, 10 μmol/l ethanolamine, 10 μmol/l sodium selenite, 0.5 mg/ml BSA.402  www.moleculartherapy.org  vol. 19 no. 2 feb. 2011     
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rESultS
differentiation of human ESc- and iPSc-derived 
definitive endoderms
Our three-step differentiation protocol is illustrated in Figure 1a. 
After treatment with 50 ng/ml of Activin A (high-dose) and basic 
fibroblast growth factor (bFGF) for 5 days on a laminin-coated 
plate, morphologically, the human ESCs and iPSCs were gradu-
ally transformed from typical, defined, tight human ESC, and iPSC 
colonies (day 0) into less dense, flatter cells containing prominent 
nuclei (day 5), even though the majority of the cells had a mor-
phology resembling that of undifferentiated cells (Figure 1b,c,f,g). 
FACS  analysis  showed  that  ~46%  of  human  iPSC-derived  dif-
ferentiated  cells  expressed  CXCR4  (expressed  in  the  definitive 
endoderm  but  not  the  primitive  endoderm)  (Supplementary 
Figure S1a). Human ESC- and iPSC-derived differentiated cells 
were  immunostained  with  the  definitive  endoderm  marker, 
FOXA2 (Figure 2a,c). However, the majority of the cells expressed 
the pluripotent marker NANOG, indicating that undifferentiated 
cells remain in the induced cultures at day 5. After the cells were 
passaged with trypsin-EDTA and seeded on a laminin-coated plate 
a second time, the resultant cells were found to be more homoge-
neous and flatter at day 6 (Figure 1d,h). Semiquantitative analy-
sis by counting immunopositive cells revealed that the number 
of FOXA2-positive cells was increased and, in turn, the number 
of NANOG-positive cells was decreased at day 6 after passaging 
(Figure 2e,f). Real-time reverse transcriptase (RT)-PCR analysis 
showed that the definitive endoderm markers FOXA2 and SOX17 
mRNA were upregulated, whereas the pluripotent marker NANOG 
mRNA was downregulated at day 6 (Figure 2g,h). These results were 
consistent with the immunofluorescence results (Figure 2a–d). The 
expression levels of the mesoderm marker FLK1 mRNA and ecto-
derm marker PAX6 mRNA were downregulated or unchanged at 
day 6 (Supplementary Figure S1b–e). Importantly, the expression 
of SOX7 mRNA (expressed in the extra-embryonic endoderm but 
not the definitive endoderm) was downregulated (Figure 2g,h). 
These results indicate that the definitive endoderm is induced or 
selected from human ESCs and iPSCs after passaging. We obtained 
the same results using another human iPSC line (Supplementary 
Figure S2a–d).
HEX induces hepatoblasts from the human  
ESc- and iPSc-derived definitive endoderms
To investigate whether forced expression of transcription factors 
could promote hepatic differentiation, the human ESC- and iPSC-
derived definitive endoderms were transduced with Ad vectors. 
We  used  a  fiber-modified  Ad  vector  containing  the  elongation 
factor-1α promoter and a stretch of lysine residue (K7) peptides 
in the C-terminal region of the fiber knob to examine the trans-
duction efficiency in the human ESC- and iPSC-derived definitive 
endoderms. The elongation factor-1α promoter was found to be 
highly active in human ESCs.28 The K7 peptide targets heparan sul-
fates on the cellular surface, and the fiber-modified Ad vector con-
taining K7 peptides was shown to be efficient for transduction into 
many kinds of cells.29,30 The human ESC- and iPSC-derived defini-
tive endoderms were transduced with a LacZ-expressing Ad vector 
(Ad-LacZ) at 3,000 vector particle/cell. X-Gal staining showed that 
the Ad-LacZ-transduced human ESC- and iPSC-derived definitive 
endoderms successfully expressed LacZ (Figure 3). Nearly 100% of 
the cells transduced with Ad-LacZ were strongly X-gal positive. The 
transduction efficiency in the human ESC- and iPSC-derived defin-
itive endoderms transduced with the conventional Ad vector con-
taining the wild-type capsid at 3,000 vector particle/cell was ~80% 
and X-gal staining was much weaker than that in the cells trans-
duced with fiber-modified Ad vectors (Supplementary Figure S6).
Next,  the  human  ESC-  and  iPSC-derived  definitive  endo-
derms were transduced with a HEX-expressing fiber-modified Ad 
vector (Ad-HEX). Although HEX is known to be a transcription 
factor that is essential for liver development, it remains unclear 
what the effect of transient HEX overexpression is on differentia-
tion from human ESCs and iPSCs or their derivatives in vitro. We 
confirmed the overexpression of HEX in the human ESC- and 
iPSC-derived  definitive  endoderms  transduced  with  Ad-HEX 
(Supplementary  Figure  S3a–f).  Gene  expression  analysis 
revealed the   upregulation of AFP mRNA, which was expressed by 
hepatoblasts or early hepatocytes, in Ad-HEX-transduced cells as 
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Figure 2  characterization of the human ESc (khES1)- and iPSc (tic) 
derived definitive endoderms. (a–d) The immunofluorescent staining of 
the human ESC (khES1)- and iPSC (Tic) derived differentiated cells before 
(a and c; day 5) and after passaging (b and d; day 6). The cells were 
immunostained with antibodies against FOXA2 and NANOG. Nuclei were 
stained with DAPI. (e,f) Semiquantitative analysis of the immunofluores-
cent staining in a–d. Data are presented as the mean of immunopositive 
cells counted in eight independent fields. (g,h) Real-time RT-PCR analy-
sis of the level of definitive endoderm (FOXA2 and SOX17), pluripotent 
(NANOG), and extra-embryonic endoderm (SOX7) gene expression at day 
5 and 6. At day 5, the cells were passaged. Therefore, the data at day 5 
and 6 show the levels of gene expression before (at day 5) or after the pas-
sage (at day 6). Data are presented as the mean ± SD from triplicate exper-
iments. The graphs represent the relative gene expression level when the 
level of undifferentiated cells at day 0 was taken as 1. Bar = 50 μm. ESC, 
embryonic stem cells; iPSC, induced pluripotent stem cells.Molecular Therapy  vol. 19 no. 2 feb. 2011  403
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compared with nontransduced cells or Ad-LacZ-transduced cells 
(Figure 4a,c). Expression of ALB mRNA, which is the most abun-
dant protein in liver, was also observed in Ad-HEX-transduced 
cells (Figure 4b,d).
During liver development, both hepatocytes and cholangio-
cytes were differentiated from the hepatoblasts. We examined the 
protein expression of AFP, ALB, and the cholangiocyte marker 
cytokeratin 7 (CK7) in Ad-HEX-transduced cells by immunostain-
ing (Figure 4e–p). The AFP-positive populations were detected 
in Ad-HEX-transduced cells (Figure 4g,m). ALB-positive cells 
were  also  detected,  although  the  detection  efficiency  was  very 
low (Figure 4j,p). CK7-positive cells were observed among the 
Ad-HEX-transduced cells, and all CK7-positive cells were found 
near the AFP- and ALB-positive cells, suggesting that hepatoblasts 
are  generated  by  the  transient  overexpression  of  a  HEX  gene. 
Semiquantitative RT-PCR analysis showed that the expression lev-
els of the liver-enriched transcription factors hepatocyte nuclear 
factor 1A, hepatocyte nuclear factor 1B, hepatocyte nuclear fac-
tor 4A, and hepatocyte nuclear factor 6 mRNA were upregulated 
in Ad-HEX-transduced cells (Supplementary Figure S4a,b). The 
expressions of CCAAT/enhancer binding protein α and prospero 
homeobox 1 mRNA, two transcription factors known to play a 
pivotal role in the establishment of the hepatoblasts, were also 
induced  in  Ad-HEX-transduced  cells  (Supplementary  Figure 
S4a, b). Taken together, these findings indicate that HEX enhances 
the specification of hepatoblasts from the human ESC- and iPSC-
derived definitive endoderms. Similar results were obtained with 
another human iPSC line (Supplementary Figure S2e–g).
time course of differentiation of the definitive 
endoderm to hepatoblasts
Next, we examined the time course of AFP and CK7 expression 
during differentiation of human iPSCs to hepatoblasts in Ad-HEX-
transduced cells and nontransduced cells. At day 7 (the day after 
transduction), the expression of AFP was not detectable in Ad-HEX-
transduced or nontransduced cells (Supplementary Figure S5a,d). 
At day 8–9, morphological changes to hepatocyte-like cells were 
observed  in  Ad-HEX-transduced  cells  (Supplementary  Figure 
S5h,i). We also observed homogeneous AFP-positive cells at day 9 
(Supplementary Figure S5e). At day 10, CK7-positive cells appeared, 
indicating that hepatoblasts started to differentiate into hepatocytes 
and cholangiocytes at day 9–10 (Supplementary Figure S5f). At 
day 12, ALB-positive cells appeared, indicating that hepatocytes 
were  differentiated  from  Ad-HEX-transduced  cells  (Figure  4p). 
These results showed that HEX induces the hepatoblasts from the 
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Figure 3  Efficient transgene expression in the human ESc (khES1)- 
and iPSc (tic) derived definitive endoderms by using a fiber-mod-
ified  Ad  vector  containing  the  EF-1α  promoter.  (a,b)  Human  ESC 
(khES1)-derived and (c,d) iPSC (Tic) derived definitive endoderms were 
transduced with 3,000 VP/cell of Ad-LacZ for 1.5 hours. The next day 
after  transduction,  X-gal  staining  was  performed  as  described  in  the 
Materials and Methods section. Similar results were obtained in two inde-
pendent experiments. Scale = 50 μm. Ad, adenovirus; EF-1α, elongation 
factor-1α; ESC, embryonic stem cells; iPSC, induced pluripotent stem 
cells; LacZ, Ad-LacZ-transduced cells; None, nontransduced cells.
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Figure 4  Efficient hepatoblast differentiation from the human ESc 
(khES1)- and iPSc (tic) derived definitive endoderms by transduction 
of the HEX gene. (a–d) Real-time RT-PCR analysis of the level of (a,c) 
AFP and (b,d) ALB expression in nontransduced cells, Ad-LacZ-transduced 
cells, and Ad-HEX-transduced cells, all of which were induced from the 
human ESC (khES1)- and iPSC (Tic) derived definitive endoderms (day 
0, 5, 6, and 12). The cells were transduced with Ad-LacZ or Ad-HEX at 
day 6 as described in Figure 1a. The data at day 6 was obtained before 
the transduction with Ad-HEX. The graphs represent the relative gene 
expression levels when the level in the fetal liver was taken as 100. (e–p) 
Immunocytochemistry of AFP, ALB, and CK7 expression in nontransduced 
cells (e,h,k, and n), Ad-LacZ-transduced cells (f,i,l, and o), and Ad-HEX-
transduced cells (g,j,m, and p) at day 12, all of which were induced 
from the human ESC (khES1)- and iPSC (Tic) derived definitive endo-
derms. Nuclei were stained with DAPI. Bar = 50 μm. Ad, adenovirus; AFP, 
α-fetoprotein; ALB, albumin; CK7, cytokeratin 7; HEX, Ad-HEX-transduced 
cells; ESC, embryonic stem cells; iPSC, induced pluripotent stem cell; LacZ, 
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definitive endoderm, and the Ad-HEX-transduced cells could dif-
ferentiate into both hepatocytes and cholangiocytes.
directed hepatic differentiation from hepatoblasts
With the protocol described above, heterogeneous populations 
containing  CK7-positive  cholangiocytes  were  observed  at  day 
12 (Figure 4p). To promote the differentiation of hepatoblasts to 
hepatocytes, the human iPSC-derived differentiated cells at day 9 
(Supplementary Figure S5e) were dislodged with trypsin-EDTA 
and plated on collagen I-coated dishes as previously reported.11 
After 8–11 days in culture with medium containing FGF4, HGF, 
OSM, and DEX, the Ad-HEX-transduced cells became more flat-
tened (Supplementary Figure S5m), whereas the nontransduced 
cells  became  fibroblast-like  cells  (Supplementary  Figure  S5i). 
Gene expression analysis showed the upregulation of ALB mRNA 
in Ad-HEX-transduced cells under this culture condition, whereas 
the expression of ALB mRNA was reduced in the nontransduced 
cells at day 18 (Figure 5b). Immunostaining showed that only a 
small percentage of Ad-HEX-transduced cells expressed ALB at 
day 12 (Figure 4p), whereas most of the Ad-HEX-transduced cells 
were ALB-positive at day 18 (Figure 5g). Most of the Ad-HEX-
transduced cells also expressed CYP3A4 at day 18 (Figure 5h). 
More  importantly,  in  the  Ad-HEX-transduced  cells,  CYP7A1 
and cytokeratin 18 were detected and these proteins are known 
to be detected in hepatocytes but not in extra-embryonic cells31,32 
(Figure 5i,j). Quantitative analysis showed that ~84, 80, 88, and 
92%  of  Ad-HEX-transduced  cells  expressed  ALB,  CYP3A4, 
CYP7A1,  and  cytokeratin  18,  respectively.  These  results  indi-
cate that Ad-HEX-transduced cells could differentiate to hepatic 
cells. However, the expression level of ALB mRNA in Ad-HEX-
transduced cells was lower than that in fetal liver tissue and in 
turn, the expression of AFP mRNA was maintained (Figure 5a). 
Therefore, Ad-HEX-transduced cells are committed to the hepatic 
linage, but are not yet mature hepatocytes.
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Ad-LacZ-transduced cells; None, nontransduced cells.Molecular Therapy  vol. 19 no. 2 feb. 2011  405
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Ad-HEX-transduced cells exhibit hepatic functions
To  test  the  hepatic  function  in  the  Ad-HEX-transduced  cells, 
we investigated the liver metabolism, because P450 cytochrome 
enzymes play a critical role in this function. We examined the 
expression level of several members of this multigene family, i.e., 
CYP3A4, CYP7A1, mRNA and CYP2D6 in Ad-HEX-transduced 
cells by real-time RT-PCR. The real-time RT-PCR analysis showed 
that  the  mRNAs  for  CYP3A4,  CYP7A1,  and  CYP2D6  were 
expressed in Ad-HEX-transduced cells, whereas none of these 
mRNAs were expressed in the nontransduced cells (Figure 6a). 
The  expression  levels  of  CYP3A4  in  Ad-HEX-transduced  cells 
were similar to those observed in primary human hepatocytes, 
which  were  cultured  48  hours  after  plating  the  cells,  or  fetal 
liver tissues but lower than those in adult liver. The CYP2D6 and 
CYP7A1 mRNA expressions in Ad-HEX-transduced cells were 
lower than those in primary hepatocytes or adult tissues. Next, 
we investigated the metabolism of the P450 3A4 substrates by 
measuring the activity of P450 isozymes. The metabolites were 
detected in Ad-HEX-transduced cells, and their activity was 3.4-
fold higher than that in the most commonly used human hepa-
tocyte cell line, HepG2 (Figure 6b; DMSO column). This result 
was consistent with the real-time RT-PCR data (Figure 6a). We 
further tested the induction of CYP3A4 upon chemical stimula-
tion, because CYP3A4 is the most prevalent P450 isozyme in the 
liver and is involved in the metabolism of a significant proportion 
of the currently available commercial drugs. Because CYP3A4 can 
be induced with rifampicin, both Ad-HEX-transduced cells and 
HepG2 cells were treated with rifampicin, followed by treatment 
with CYP3A4 substrate. Ad-HEX-transduced cells produced 5.4-
fold higher levels of metabolites in response to rifampicin treat-
ment (Figure 6b; rifampicin column). This result indicates that 
P450 isozymes are active in Ad-HEX-transduced cells.
dIScuSSIon
The object of this study was to develop an efficient method for 
generating hepatoblasts and hepatocytes from human ESCs and 
iPSCs for application to drug toxicity screening tests as well as 
therapeutics such as regenerative medicine. We found that tran-
sient HEX transduction in the definitive endoderm together with 
a culture under chemically defined conditions was useful for this 
purpose.
It  has  been  reported  that  a  high  concentration  of  Activin 
A  induces  differentiation  of  human  ESCs  into  the  definitive 
endoderm.8,33,34 On the other hand, undifferentiated human ESCs 
are maintained by a low concentration of Activin A.35 Several 
studies  have  shown  that  bFGF  promotes  the  differentiation  of 
ESCs into the definitive endoderm and inhibits the differentia-
tion of ESCs into the extra-embryonic endoderm.35–38 bFGF has 
been reported to inhibit the BMP signaling, which can promote 
the extra-embryonic lineage differentiation.39 The extra-embry-
onic endoderm expresses most of the hepatocyte markers, such as 
AFP.40 Contamination of the extra-embryonic endoderm makes it 
difficult to estimate the hepatic differentiation from human ESCs 
and iPSCs.11,14,40 In this study, we showed that both Activin A and 
bFGF induce definitive endoderm populations, while they repress 
the  extra-embryonic  endoderm  differentiation  (Figure  2g,h). 
Interestingly, after the differentiated cells that were cultured on 
laminin-coated plates with Activin A and bFGF were passaged at 
day 5, FOXA2-positive cells (definitive endoderm) were enriched 
in the resultant cells at day 6 (Figure 2a–f). This may have been 
because FOXA2-positive cells efficiently adhered to the laminin-
coated plate and/or because trypsinized, single undifferentiated 
ESCs/iPSCs cannot survive. The passaging of differentiated cells 
might be attributed to the reduction in the number of not only 
the extra-embryonic endoderm cells but also the undifferentiated 
cells. However, the efficiency of the definitive endoderm differen-
tiation in this study was not as efficient as that reported by other 
groups.8,33,34 Other cell lineages, such as the mesoderm and extra-
embryonic endoderm, might remain at day 6 (Figure 2g,h and 
Supplementary Figure S1). Further improvement of the culture 
conditions will thus be needed in order to enhance the definitive 
endoderm differentiation.
Hepatoblasts  and  hepatocytes  were  differentiated  from  the 
human ESC- and iPSC-derived definitive endoderms by transient 
overexpression  of  the  homeobox  gene  HEX.  A  fiber-modified 
Ad vector containing K7 peptides mediated much higher gene 
expression than conventional Ad vectors in the human ESC- and 
iPSC-derived definitive endoderms (Supplementary Figure S6). 
This new hepatic differentiation protocol shows that HEX induces 
AFP-positive hepatoblasts at day 9 and ALB-positive hepatocytes 
at day 12 from human ESCs and iPSCs, whereas the previous pro-
tocols require a few weeks or months to induce AFP- and ALB-
positive hepatocytes from PSCs.9–11 Previous studies suggested that 
HEX could regulate liver-enriched transcription factors such as 
hepatocyte nuclear factor 4A and hepatocyte nuclear factor 6.19,23 
Overexpression of the HEX gene under the conditions employed 
in the present study could activate several transcription factors that 
are required for hepatic differentiation (Supplementary Figure 
S4a,b). However, the Ad-HEX-transduced cells showed a low level 
of expression of ALB and some CYP450 species, as well as a high 
level of AFP expression, indicating that the cells were still imma-
ture. To promote further hepatic differentiation or maturation, it 
may be effective to culture the hepatic cells in a 3D environment 
or on feeder cells such as cardiomyocyte- or endothelium-derived 
cells.41,42 In addition, the function of our hepatic cells was still lim-
ited. Further analysis of the other functions of our hepatic cells, 
such as glycogen storage, uptake of indocyanine green and organic 
anion low-density lipoprotein, and transplantation of Ad-HEX-
transduced cells into the liver of immunodeficient mice, is clearly 
needed  for  the  appreciation  to  drug  screening  and  therapeutic 
treatment modalities.
During the preparation of this article, Kubo et al. have reported 
that HEX could promote hepatoblast differentiation from mouse 
ESCs.43 Their report is consistent with our data, suggesting that HEX 
plays a pivotal regulatory role in not only mouse but also human 
hepatic differentiation. They also showed that the overexpression 
of HEX at the definitive endoderm stage is critical for hepatic spec-
ification of the mouse ESCs. We also confirmed that forced expres-
sion of HEX in the undifferentiated human ESCs and iPSCs did not 
elevate the expression of ALB and CK7 (Supplementary Figure 
S7), indicating that HEX enhances the hepatic differentiation not 
from the undifferentiated cells but from the definitive endoderm. 
However, Kubo et  al. used recombinant mouse ESCs (tet-HEX 
ESCs), in which the tetracycline-regulated HEX expression cassette 406  www.moleculartherapy.org  vol. 19 no. 2 feb. 2011     
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is integrated into the host cell genome to induce HEX in a stage-
specific manner. Their system would not be appropriate for clini-
cal use because the transgene is randomly integrated into the host 
cell genome and this leads to a risk of mutagenesis.44 On the other 
hand, we generated human hepatoblasts by Ad vector-mediated 
transient HEX transduction, method which avoids the integration 
of exogenous DNA into the host chromosome.
Touboul et al. reported that human ESCs and iPSCs can dif-
ferentiate into functional hepatocytes under chemically defined 
conditions.34 In the present study, hepatoblasts were generated 
in a chemically defined serum-free medium, which minimized 
exposure to animal cells and proteins, and on a defined extracel-
lular matrix, such as laminin or collagen, which do not contain 
undefined growth factors. To generate hepatocytes, hepatocyte 
culture medium, which is serum-free but not defined, was used in 
the stage III. When defined hESF-medium was used in the stage 
III, the expression levels of ALB and CYP3A4 mRNA were half the 
levels seen in the cells cultured with hepatocyte culture medium in 
the preliminary experiment (data not shown). Human ESCs and 
iPSCs were also grown for maintaining the undifferentiated state 
on a feeder layer, which contains xenoantigen such as bovine apo-
lipoprotein B-100. Bovine apolipoprotein B-100 is known to be 
a dominant xenoantigen for cell-based therapies.45 Human ESC- 
and iPSC-derived hepatocytes should be generated and cultured 
under chemically defined conditions not only to avoid potential 
contamination with pathogens for the safer therapeutic applica-
tion, but also to obtain reproducible results using the differentia-
tion protocols.34,46 Development of differentiation protocols using 
other genes of transcription factors as well as HEX genes based on 
a chemically defined medium is under way. Overall, our strategy 
should provide a novel protocol for hepatic differentiation from 
human ESCs and iPSCs, which could be useful for regenerative 
medicine and drug screening.
MAtErIAlS And MEtHodS
Ad vectors. Ad vectors were constructed by an improved in vitro ligation 
method.47,48 The human HEX complementary DNA derived from pDNR-
LIB-HEX (Invitrogen, Carlsbad, CA) was inserted into pHMEF5,29 which 
contains the human elongation factor-1α promoter, resulting in pHMEF-
HEX. The pHMEF-HEX was digested with I-CeuI/PI-SceI and ligated into 
I-CeuI/PI-SceI-digested pAdHM41-K7,30 resulting in pAd-HEX. Ad-HEX 
and Ad-LacZ, both of which contain the elongation factor-1α promoter and 
a stretch of lysine residues (K7) peptides in the C-terminal region of the 
fiber knob, were generated and purified as described previously.26,29 The vec-
tor particle titer was determined by using a spectrophotometric method.49
Human ESCs and iPSCs culture. A human ESC line, khES1, was obtained 
from Kyoto University (Kyoto, Japan).50 khES1 was used following the 
Guidelines for Derivation and Utilization of Human Embryonic Stem Cells 
of the Ministry of Education, Culture, Sports, Science and Technology 
of Japan after approval by the review board at Kyoto University. Human 
ESCs were maintained on a feeder layer of mitomycin-inactivated mouse 
embryonic fibroblasts (ICR; ReproCELL Incorporated, Tokyo, Japan) with 
Dulbecco’s modified Eagle’s medium/F-12 (Sigma, St Louis, MO) supple-
mented  with  0.1 mmol/l  2-mercaptoethanol,  0.1 mmol/l  nonessential 
amino acids, 2 mmol/l l-glutamine, 20% GIBCO knockout serum replace-
ment (Invitrogen), and 5 ng/ml bFGF (Sigma) in a humidified atmosphere 
of 3% CO2 and 97% air at 37 °C. Human ESCs were dissociated with 0.1 mg/
ml dispase (Roche Diagnostics, Burgess Hill, UK) into small clumps, and 
subcultured every 5 or 6 days.
Two  human  iPS  clones  derived  from  the  embryonic  human  lung 
fibroblast cell line MCR5 were provided from JCRB Cell Bank (Tic, JCRB 
Number:  JCRB1331;  and  Dotcom,  JCRB  Number:  JCRB1327).3,4  In 
the present study, we mainly used the Tic cell line, but similar results 
were obtained using the Dotcom cell line, and these are shown in the 
supplementary figures. Human iPSCs were maintained on a feeder layer 
of mitomycin-inactivated mouse embryonic fibroblasts (Hygro Resistant 
Strain  C57/BL6;  Hygro,  Millipore,  MA)  on  a  gelatin-coated  flask  in 
human iPS medium. Human iPS medium consists of knockout Dulbecco’s 
modified Eagle’s medium/F12 (Invitrogen), supplemented with 0.1 mmol/l 
2-mercaptoethanol,  0.1 mmol/l  nonessential  amino  acids,  2 mmol/l  l-
glutamine, 20% knockout serum replacement, and 10 ng/ml bFGF in a 
humidified atmosphere of 5% CO2 and 95% air at 37 °C. Human iPSCs 
were dissociated with 0.1 mg/ml dispase (Roche) into small clumps and 
subcultured every 7 or 8 days.
In vitro differentiation. Before the initiation of cellular differentiation, the 
medium of human ESCs and iPSCs was exchanged for a defined serum-free 
medium hESF9 and cultured in a humidified atmosphere of 10% CO2 and 
90% air at 37 °C.46 hESF9 consists of hESF-GRO medium (Cell Science & 
Technology Institute, Sendai, Japan) supplemented with five factors (10 μg/
ml human recombinant insulin, 5 μg/ml human apotransferrin, 10 μmol/l 
2-mercaptoethanol, 10 μmol/l ethanolamine, 10 μmol/l sodium selenite), 
oleic acid conjugated with fatty acid free bovine ALB, 10 ng/ml bFGF, and 
100 ng/ml heparin (all from Sigma). For induction of definitive endoderm, 
human ESCs and iPSCs were dissociated into single cells with Accutase 
(Invitrogen) and cultured for 5 days on a mouse laminin-coated tissue 
12-well plate (6.0 × 104 cells/cm2) in hESF-GRO medium (Cell Science & 
Technology Institute) supplemented with the five factors, 0.5 mg/ml fatty 
acid free bovine ALB (BSA) (Sigma), 10 ng/ml bFGF, and 50 ng/ml Activin 
A (R&D Systems, Minneapolis, MN) in a humidified atmosphere of 10% 
CO2 and 90% air at 37 °C. The medium was refreshed every day.
For  induction  of  hepatoblasts,  the  human  ESC-  and  iPSC-derived   
definitive  endoderms  (day  5)  were  dissociated  with  0.0125%  trypsin- 
0.01325 mmol/l EDTA, and then the trypsin was inactivated with 0.1% 
soybean trypsin inhibitor (Sigma). The cells were seeded at 1.2 × 105 cells/
cm2 on a laminin-coated 12-well plate with hESF-DIF (Cell Science & 
Technology Institute) medium supplemented with the five factors, 0.5 mg/ml   
BSA, 10 ng/ml bFGF, and 50 ng/ml Activin A in a humidified atmosphere 
of 10% CO2 and 90% air at 37 °C. The next day, the cells were transduced 
with 3,000 vector particle/cell of Ad vectors (Ad-HEX and Ad-LacZ) for 
1.5 hours in hESF-DIF medium supplemented with the five factors, BSA, 
10 ng/ml FGF4 (R&D Systems) and 10 ng/ml BMP4 (R&D Systems).10 The 
medium was refreshed every day.
For induction of hepatocytes, human iPSC-derived hepatoblasts in 
one well (day 9) were passaged onto two wells with 0.0125% trypsin-
0.01325mmol/l EDTA and 0.1% trypsin inhibitor, on type I collagen-
coated tissue 12-well plate (15 μg/cm2) (Nitta Gelatin, Osaka, Japan). The 
cells were cultured in hepatocyte culture medium supplemented with 
SingleQuots (Lonza, Walkersville, MD), 10 ng/ml FGF4, 10 ng/ml HGF 
(R&D Systems), 10 ng/ml Oncostatin M (R&D Systems), and 0.392 ng/ml 
dexamethasone (Sigma).11 The medium was refreshed every 2 days.
RNA isolation, RT-PCR, immunostaining, flow cytometry, lacz assay, 
and assay for cytochrome P4503A4 activity. For details of these pro-
cedures, See Supplementary Materials and Methods, Supplementary 
Tables S1 and S2.
SuPPlEMEntArY MAtErIAl
Figure  S1.  Characterization  of  the  human  ESC  (khES1)-  and  iPSC 
(Tic)-derived definitive endoderms.
Figure  S2.  Efficient  differentiation  of  another  human  iPSC  line 
(Dotcom) into hepatoblasts by overexpression of the HEX gene.
Figure S3.  Overexpression of HEX in the human ESC (khES1)- and 
iPSC (Tic)-derived definitive endoderms.Molecular Therapy  vol. 19 no. 2 feb. 2011  407
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Figure S4.  Characterization of Ad-HEX-transduced hepatoblasts.
Figure S5.  Progression of differentiation of the definitive endoderm 
to hepatoblasts.
Figure S6.  X-gal staining of human iPSC (Tic)-derived definitive en-
doderms transduced with a conventional or a fiber-modified Ad vector 
containing the EF-1α promoter.
Figure S7.  HEX promotes the differentiation into the hepatic lineage, 
not from undifferentiated iPSCs (Tic), but from iPSC (Tic)-derived de-
finitive endoderm.
Table S1.  List of Taqman gene expression assays and primers.
Table S2.  List of antibodies used.
Materials and Methods.
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